Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125209581 | 12520958 | 1 | I | 20120717 | 20131118 | 20160701 | 20160701 | EXP | JP-GLAXOSMITHKLINE-B0947307A | GLAXOSMITHKLINE | 18.21 | YR | M | Y | 40.00000 | KG | 20160701 | CN | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125209581 | 12520958 | 1 | SS | Ambrisentan | AMBRISENTAN | 1 | Oral | 65 | MG | 0 | 2.5 | MG | TABLET | QD | |||||
| 125209581 | 12520958 | 2 | SS | Ambrisentan | AMBRISENTAN | 1 | Oral | 2.5 MG, BID | 65 | MG | 0 | 2.5 | MG | TABLET | BID | ||||
| 125209581 | 12520958 | 3 | SS | Ambrisentan | AMBRISENTAN | 1 | Oral | 5 MG, QD | 65 | MG | 0 | 5 | MG | TABLET | QD | ||||
| 125209581 | 12520958 | 4 | PS | EPOPROSTENOL SODIUM. | EPOPROSTENOL SODIUM | 1 | Intravenous (not otherwise specified) | UNK | 20444 | SOLUTION FOR INJECTION | |||||||||
| 125209581 | 12520958 | 5 | SS | EPOPROSTENOL SODIUM. | EPOPROSTENOL SODIUM | 1 | Intravenous (not otherwise specified) | UNK | 20444 | SOLUTION FOR INJECTION | |||||||||
| 125209581 | 12520958 | 6 | SS | EPOPROSTENOL SODIUM. | EPOPROSTENOL SODIUM | 1 | Intravenous (not otherwise specified) | UNK | 20444 | SOLUTION FOR INJECTION | |||||||||
| 125209581 | 12520958 | 7 | SS | EPOPROSTENOL SODIUM. | EPOPROSTENOL SODIUM | 1 | Intravenous (not otherwise specified) | UNK | 20444 | SOLUTION FOR INJECTION | |||||||||
| 125209581 | 12520958 | 8 | SS | EPOPROSTENOL SODIUM. | EPOPROSTENOL SODIUM | 1 | Intravenous (not otherwise specified) | UNK | 20444 | SOLUTION FOR INJECTION | |||||||||
| 125209581 | 12520958 | 9 | SS | EPOPROSTENOL SODIUM. | EPOPROSTENOL SODIUM | 1 | Intravenous (not otherwise specified) | UNK | 20444 | SOLUTION FOR INJECTION | |||||||||
| 125209581 | 12520958 | 10 | SS | EPOPROSTENOL SODIUM. | EPOPROSTENOL SODIUM | 1 | Intravenous (not otherwise specified) | UNK | 20444 | SOLUTION FOR INJECTION | |||||||||
| 125209581 | 12520958 | 11 | SS | EPOPROSTENOL SODIUM. | EPOPROSTENOL SODIUM | 1 | Intravenous (not otherwise specified) | UNK | 20444 | SOLUTION FOR INJECTION | |||||||||
| 125209581 | 12520958 | 12 | SS | EPOPROSTENOL SODIUM. | EPOPROSTENOL SODIUM | 1 | Intravenous (not otherwise specified) | UNK | 20444 | SOLUTION FOR INJECTION | |||||||||
| 125209581 | 12520958 | 13 | SS | REVATIO | SILDENAFIL CITRATE | 1 | Oral | UNK | 0 | ||||||||||
| 125209581 | 12520958 | 14 | SS | VANCOMYCIN | VANCOMYCIN | 1 | UNK | Y | 0 | ||||||||||
| 125209581 | 12520958 | 15 | SS | VANCOMYCIN | VANCOMYCIN | 1 | Intravenous (not otherwise specified) | UNK | Y | 0 | |||||||||
| 125209581 | 12520958 | 16 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | UNK | U | 0 | ORAL DRUG UNSPECIFIED FORM | ||||||||
| 125209581 | 12520958 | 17 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | Oral | UNK | U | 0 | TABLET | ||||||||
| 125209581 | 12520958 | 18 | C | Gluconsan K | 2 | Oral | UNK | U | 0 | ORAL DRUG UNSPECIFIED FORM |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125209581 | 12520958 | 1 | Pulmonary arterial hypertension |
| 125209581 | 12520958 | 4 | Pulmonary arterial hypertension |
| 125209581 | 12520958 | 14 | Device related infection |
| 125209581 | 12520958 | 16 | Pulmonary arterial hypertension |
| 125209581 | 12520958 | 17 | Pulmonary arterial hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125209581 | 12520958 | HO |
| 125209581 | 12520958 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125209581 | 12520958 | Device related infection | |
| 125209581 | 12520958 | Haemoptysis | |
| 125209581 | 12520958 | Red man syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125209581 | 12520958 | 1 | 20110526 | 20120703 | 0 | |
| 125209581 | 12520958 | 2 | 20120704 | 20121128 | 0 | |
| 125209581 | 12520958 | 3 | 20121129 | 0 | ||
| 125209581 | 12520958 | 4 | 20120411 | 0 | ||
| 125209581 | 12520958 | 5 | 20120411 | 20120509 | 0 | |
| 125209581 | 12520958 | 6 | 20120509 | 20120606 | 0 | |
| 125209581 | 12520958 | 7 | 20120606 | 20130619 | 0 | |
| 125209581 | 12520958 | 8 | 20130619 | 20130717 | 0 | |
| 125209581 | 12520958 | 9 | 20130717 | 20150220 | 0 | |
| 125209581 | 12520958 | 10 | 20150220 | 20150318 | 0 | |
| 125209581 | 12520958 | 11 | 20150318 | 20150422 | 0 | |
| 125209581 | 12520958 | 12 | 20150422 | 0 | ||
| 125209581 | 12520958 | 14 | 20120719 | 20120723 | 0 | |
| 125209581 | 12520958 | 15 | 20140714 | 20140714 | 0 |